Incyte (INCY) EPS (Diluted) (2009 - 2026)
Incyte (INCY) recorded EPS (Diluted) of -$3.86 in Q3 2026, compared with $2.11 a year earlier.
Powered by 
Analysis
Incyte (INCY) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a TTM basis, Incyte's EPS (Diluted) came in at $1.98 as of Sep 30, 2026, down 66.4% year-over-year; for FY2025, it was $6.41.
- Across earlier years, EPS (Diluted) came in at $0.15 in FY2024 (-94.1%), $2.65 in FY2023 (+73.9%), $1.52 in FY2022 (-64.4%) and $4.27 in FY2021.
- The Q3 2026 figure is the lowest quarterly EPS (Diluted) in data going back to Q1 2010.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 675.6% in Q1 2024, against a decline of 95.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.81 (Q2 2026), $1.47 (Q1 2026) and $1.49 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.56 |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -386.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -386.13 |
| Jun 30, 2026 | 281.25 |
| Mar 31, 2026 | 146.66 |
| Dec 31, 2025 | 149.12 |
| Sep 30, 2025 | 210.58 |
| Jun 30, 2025 | 203.78 |
| Mar 31, 2025 | 79.82 |
| Dec 31, 2024 | 95.57 |
| Sep 30, 2024 | 54.36 |
| Jun 30, 2024 | -203.78 |
| Mar 31, 2024 | 74.62 |
| Dec 31, 2023 | 89.00 |
| Sep 30, 2023 | 75.73 |
| Jun 30, 2023 | 90.21 |
| Mar 31, 2023 | 9.62 |
| Dec 31, 2022 | 12.71 |
| Sep 30, 2022 | 50.31 |
| Jun 30, 2022 | 72.18 |
| Mar 31, 2022 | 17.04 |
| Dec 31, 2021 | 253.90 |
API Access
Incyte EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();